Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
- RabMAb
- Recombinant
- What is this?
2
(1 Review)
|
(23 Publications)
Rabbit Recombinant Monoclonal PHD1/prolyl hydroxylase antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 23 publications.
View Alternative Names
EIT6, EGLN2, Prolyl hydroxylase EGLN2, Egl nine homolog 2, Estrogen-induced tag 6, HPH-3, Hypoxia-inducible factor prolyl hydroxylase 1, Prolyl hydroxylase domain-containing protein 1, EIT-6, HIF-PH1, HIF-prolyl hydroxylase 1, HPH-1, PHD1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)
Immunohistochemical analysis of paraffin-embedded Human ovarian adenocarcinoma tissue using ab108980
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)
Immunofluorescent staining of HeLa cells using ab108980
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)
Immunohistochemical analysis of paraffin-embedded Human testis tissue using ab108980
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)
Overlay histogram showing HeLa cells stained with ab108980 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab108980 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5000 events was performed.
- WB
Unknown
Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)
All lanes:
Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (ab108980) at 1/1000 dilution
Lane 1:
A549 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
MCF-7 cell lysate at 10 µg
Secondary
All lanes:
Standard HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 44 kDa
false
- WB
CiteAb
Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)
Western Blotting using Anti-PHD1/prolyl hydroxylase antibody [EPR2745], ab108980. Publication image from Hsu, T. S. et al., 2016, Nat Commun, 27312851. Legend direct from paper.
DAPK interacts with PHD2 and increases PHD2-HIF-1α association.(a) Interaction of DAPK with PHD2. Jurkat cells were transfected with FLAG-PHD2 and DAPK-Myc. The whole-cell lysates (WCL) were immunoprecipitated with anti-Myc, and the contents of FLAG-PHD2 and DAPK-Myc in the precipitates and WCL were determined by anti-FLAG and anti-Myc. (b) Co-localization of DAPK with PHD2 in Th17 cells. WT naive T cells were differentiated into Th17 for 2 days, and cells were fixed. Fixed cells were stained with anti-PHD2, anti-DAPK and DAPI, and analysed by confocal microscopy. Scale bar, 2.5 µm. (c) Co-localization of HIF-1α with PHD2 in Th17 cells. Th17 cells were stained with anti-PHD2, anti-HIF-1α and DAPI, and analysed by confocal microscopy. Scale bar, 2.5 µm. (d) DAPK interacts with the N-terminal domain of PHD2. HEK293T cells were transfected with DAPK-Myc, and the N-terminal (aa 1–180) or C-terminal (aa 181–426) domain of FLAG-PHD2 as indicated. Cell lysates were immunoprecipitated with anti-Myc, and the contents of PHD2 and DAPK were determined. (e) DAPK increases the association of PHD2 with HIF-1α in vitro. Recombinant GST-HIF-1α protein was incubated with FLAG-PHD2 in the absence or presence of recombinant DAPK-FLAG proteins in PBS at 4 °C for 4 h. The GST-HIF-1α complex was pulled down by anti-GST, and the contents of FLAG-PHD2, GST-HIF-1α and DAPK-FLAG in the precipitates and incubation mixtures were determined. Data (a–e) are representative of two independent experiments.
false
- WB
CiteAb
Western blot - Anti-PHD1/prolyl hydroxylase antibody [EPR2745] (AB108980)
Western Blotting using Anti-PHD1/prolyl hydroxylase antibody [EPR2745], ab108980. Publication image from Hsu, T. S. et al., 2016, Nat Commun, 27312851. Legend direct from paper.
DAPK promotes PHD2-dependent HIF-1α degradation.(a) Deletion of the oxygen-dependent degradation (ODD) region confers resistance of HIF-1α to DAPK-induced degradation. HEK293T cells were transfected with DAPK-FLAG and HIF-1α[δODD] and the levels of HIF-1α were determined 48 h after transfection. (b) PHD inhibitor prevents DAPK-induced HIF-1α degradation in normal T cells. Naive T cells were activated for 48 h and transduced with vector or DAPK-FLAG-IRES-GFP. GFP+ T cells were sorted 48 h later, switched to hypoxic incubation (1% O2) in the absence or presence of DFX (10 µM) for another 24 h, and the levels of DAPK-FLAG and HIF-1α were determined. (c) DAPK deficiency decreases proline hydroxylation of HIF-1α in normal T cells. Naive WT and Dapk−/− T cells were activated with anti-CD3/CD28 for 48 h in normoxic conditions, followed by treatment with MG132 (10 µM). The extents of Pro564 hydroxylation on HIF-1α were determined at the indicated time points. (d) DAPK enhances proline hydroxylation of HIF-1α. YFP control and DAPK-FLAG-expressing Jurkat cells were treated with MG132 (5 µM) in normoxic conditions. The extents of Pro564 hydroxylation on HIF-1α were determined at the indicated time points. (e) Mutation of proline hydroxylation sites confers resistance of HIF-1α to DAPK-induced degradation in T cells. Jurkat cells were transfected with DAPK-FLAG, HIF-1α-WT or HIF-1α[P402A/P564A] (HIF-1α-2PA), as indicated. Twenty-four hours after transfection, cells were incubated under hypoxic conditions (1% O2) for 6 h, then switched back to normoxia for 10 min, and the levels of HIF-1α were determined. (f) DAPK deficiency does not affect the expression of PHD1 and PHD2. WT and Dapk−/− naive CD4 T cells were allowed to differentiate into Th17 cells for 3 days. Cells were harvested and the expression of PHD1 and PHD2 was examined. (g) PHD2-knockdown prevents DAPK-induced HIF-1α degradation in T cells. Jurkat T cells were transfected with DAPK-FLAG, siRNA control (siCtrl), or siRNA for PHD2 (siPHD2). Twenty-four hours later, cells were switched to hypoxic conditions for 6 h, and the levels of HIF-1α, PHD2 and HSP90 were determined. Data are representative of three (a,d) or two (b,c,e–g) independent experiments.
false
Related conjugates and formulations (9)
-
Anti-PHD1/prolyl hydroxylase antibody [EPR2745] - BSA and Azide free
-
660 APC
APC Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
-
HRP Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
-
578 PE
PE Anti-PHD1/prolyl hydroxylase antibody [EPR2745]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PHD1 modulates the stability of the hypoxia-inducible factor (HIF) proteins which are key regulators of oxygen homeostasis in the cell. Under normoxic conditions PHD1 hydroxylates specific proline residues on HIF-alpha marking it for degradation via the ubiquitin-proteasome pathway. This enzyme does not function as part of a larger protein complex but it plays a pivotal role in determining the cellular response to oxygen levels. Additionally PHD1 expression affects the metabolic adaptation processes and energy expenditure in cells.
Pathways
PHD1 plays a role in the cellular response to hypoxia and is integral to the HIF signaling pathway. It interacts directly with HIF-alpha subunits mediating their degradation under normal oxygen conditions to ensure HIF activity remains inhibited. Additionally PHD1 is indirectly involved in modulating the angiogenesis pathway as it influences the availability of HIF-related transcription factors which promote transcription of vascular endothelial growth factor (VEGF) under low oxygen conditions. The interplay between PHD1 PHD2 and PHD3 ensures a fine-tuned regulation of the HIF pathway based on oxygen availability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in physiology 15:1488152 PubMed39882327
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 22:248 PubMed38454480
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Lung cellular and molecular physiology 325:L741-L755 PubMed37847687
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bone research 11:7 PubMed36650133
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 19:177 PubMed35810304
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Lung cellular and molecular physiology 323:L129-L141 PubMed35762602
2022
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 100:e27059 PubMed34477138
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 18:1849-1861 PubMed34339019
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:670913 PubMed34178995
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American Society of Gene Therapy 29:2134-2150 PubMed33601056
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com